Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Steven Davis

Trial Manager - Oncology Clinical Trials Office (OCTO)

I joined the Oncology Clinical Trials Office (OCTO) as a Trial Manager in November 2017. Prior to this I was a Trial Coordinator and Data Manager at the Cancer Trials Centre, University College London. 

I am currently working on 3 different oncology studies;

NEOPANC-01 - A phase 0, pre-operative, window-of-opportunity study to assess gene expression in patients with resectable pancreatic cancer. 

CEDAR - A Phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer

OxPLoreD - Oxford Pre-cancerous Lymphoproliferative Disorders: Analysis and Interception study

Further information on these and all other OCTO trials can be found here